About 491,005 results

Contraceptive use boosted by enhanced counseling
Heidi Splete

May 23rd, 2022 - Contraceptive counseling and interventions beyond usual care significantly increased the use of contraceptives with no accompanying increase in sexually transmitted infections or reduction in condom use, based on data from a new meta-analysis. “Although effective contraception is available in the United States and guidelines support contraceptive care in clinical practice, providing contracepti.

Downtime? Enjoy it
Allan M. Block, MD

May 23rd, 2022 - Everything in medicine, and pretty much the universe, is based on averages. Average reduction of seizures, average blood levels, average response to treatment, average insurance reimbursement, average time spent with a new consult.

Doxycycline bests azithromycin for anorectal chlamydia in women
Marilynn Larkin

May 23rd, 2022 - NEW YORK (Reuters) – A one-week course of doxycycline was superior to a single dose of azithromycin in women with concurrent vaginal and anorectal chlamydia infection in an unblinded randomized controlled trial, mirroring previous results in men. Researchers suggest that doxycycline should be the first-line therapy for chlamydia infection in women.

Advice from the Trenches on Type 2 Diabetes Care
Davida F. Kruger, MSN, APRN-BC, BC-ADM

May 23rd, 2022 - Davida F. Kruger, MSN, APN-BC, BC-ADM Ms.

National Poll: Safety not always top of mind for parents choosing kids' summer camps

May 23rd, 2022 - When it comes to picking a summer camp for kids, logistics top the checklist for most parents, a new national poll suggests. And while families consider health and safety information, such as camp supervision and first aid training, less than half of parents rate general safety policies as essential to their camp decision, according to the University of Michigan Health C.S. Mott Children’s Hosp...

Biden says monkeypox not as concerning as Covid
CNN Liptak K, Howard J.

May 23rd, 2022 - (CNN)US President Joe Biden said Monday he doesn't believe an outbreak of monkeypox is as risky as the Covid-19 pandemic, tempering comments he made a day earlier that people should be "concerned." "We have had this monkeypox in large numbers in the past. We have vaccines to take care of it," Biden said during a visit to Tokyo.

Treatment for alcohol abuse reduces hepatitis readmission
Laird Harrison

May 22nd, 2022 - SAN DIEGO – Treating people with alcoholic hepatitis for alcohol abuse may reduce their risk of hospital readmission, researchers reported. In a retrospective analysis of nationwide data, 7.

Taste buds can adapt to low salt diet

May 22nd, 2022 - Madrid, Spain – 22 May 2022: A taste adaptation intervention lowers salt intake and increases enjoyment of a sodium restricted diet in patients with hypertension, according to a small study presented at ACNAP-EuroHeartCare Congress 2022, a scientific congress of the European Society of Cardiology (ESC).1 “One of the major barriers to sticking to a low salt diet is that people do not like the ta...

Speech analysis app predicts worsening heart failure before symptom onset

May 21st, 2022 - Madrid, Spain – 21 May 2022: A voice analysis app used by heart failure patients at home recognises fluid in the lungs three weeks before an unplanned hospitalisation or escalation in outpatient drug treatment. The late breaking research is presented at Heart Failure 2022, a scientific congress of the European Society of Cardiology (ESC).1 “The current standard of care just isn’t good enough fo...

SCAI announces Early Career Research Grants

May 21st, 2022 - ATLANTA (May 21, 2022) – Today during the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions in Atlanta, SCAI President Sunil V. Rao, MD, FSCAI, announced the establishment of the SCAI Early Career Research Grants. As cardiovascular disease (CVD) morbidity and mortality in the United States continues to rise, federal funding dedicated to CVD research has rema...

The anxious patient needs psychosomatic primary care
Horst Gross, MD

May 20th, 2022 - A balance between fear and relaxation is normal. However, mental dispositions and the continuous influence of environmental stimuli can disrupt this balance.

European committee recommends approval of baricitinib for severe alopecia areata
Doug Brunk

May 20th, 2022 - The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of baricitinib, a Janus kinase (JAK) inhibitor, for the treatment of adults with severe alopecia areata (AA). The development, which was announced in a May 20, 2022, press release from the manufacturer, Eli Lilly and Incyte, marks the first step toward European regulatory approva.

Obesity and lung disease: Much more than BMI
Christine Kilgore

May 20th, 2022 - The diverse effects of obesity on lung health and disease are increasingly being teased apart, with researchers honing in on the impact of metabolic dysfunction, circulating inflammatory factors produced by adipose tissue, lipid handling, and other factors – in addition to body mass index – that are associated with the obese state. “The bird’s eye view is that obesity completely changes lung he.

FAQs on Philips Respironics Ventilator, BiPAP Machine, and CPAP Machine Recalls
MedWatch; FDA

May 20th, 2022 - UPDATE: On May 19, 2022, the FDA updated this web page to help ensure patients and providers have important information about the recall of these critical devices. See What the FDA is Doing for more information. Philips Respironics (Philips) voluntarily recalled certain ventilators, bi-level positive airway pressure (also known as Bilevel PAP, BiPAP, or BPAP) machines, and continuous positive a...

Update: Certain Philips Respironics Ventilators, BiPAP Machines, and CPAP Machines Reca...
MedWatch; FDA

May 20th, 2022 - UPDATE: On May 19, 2022, the FDA updated this safety communication to provide the latest information about medical device reports (MDRs) associated with the breakdown of the polyester-based polyurethane (PE-PUR) foam used in the Philips Respironics ventilator, BiPAP machine, and CPAP machine recalls. In addition, the FDA has taken additional actions since this updated safety communication was i...

Advances In Neurologic Care

May 20th, 2022 - Read Now Pharmacist Impact on Access to Care in an Epilepsy Clinic MRI Protocols for Veterans With Multiple Sclerosis Neuroimaging in the Era of Artificial Intelligence Autonomic Dysfunction in CADASIL Syndrome.

Fast Five Quiz: Thrombocytopenia

May 20th, 2022 - Thrombocytopenia is an abnormally low platelet count with various causes. Low levels of platelets present risks such as bleeding and thrombosis. The National Organization for Rare Diseases (NORD) estimates that more than 200,000 people have primary immune thrombocytopenia (ITP) worldwide; the incidence among adults in the United States is 3.3 cases per 100,000 adults/year. Would you be able to ...

Researchers highlight crisis in dental care for people with severe mental illness

May 20th, 2022 - People with severe mental illnesses are falling through the cracks when it comes to oral health care, according to new research. The study explores the reasons why people with severe mental illness – such as Schizophrenia and bipolar disorder – struggle to maintain good oral health and access dental care, leaving them three times more likely than the general population to lose all their teeth. ...

Long term use of clopidogrel monotherapy associated with lower patient risk compared to aspirin monotherapy

May 20th, 2022 - ATLANTA, GA (May 20, 2022) – Results from a real-world study investigating safety and effectiveness of clopidogrel versus aspirin monotherapy beyond 12 months after PCI in high-risk patients during the chronic maintenance period. This study found that clopidogrel monotherapy was associated with reduced risk of net adverse clinical events (NACE; all-cause death, MI, stent thrombosis, stroke, or ...

New long-term data of paclitaxel devices continues to show no increased mortality compared to non-drug coated devices

May 20th, 2022 - ATLANTA, GA (May 20, 2022) – New long-term data from the Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD) study were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions. The analysis found no meaningful difference in survival between patients treated ...